跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CBT-1
首页
药物
CBT-1
CBT-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES
申请人: SERUM INST OF INDIA PVT LTD
优先权: 2009
EP
US
WO
10 件公开
CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS FOR RNA EDITING
申请人: AIRNA CORP
优先权: 2023
CN
EP
US
WO
4 件公开
OPTIMIZED ANTISENSE SEQUENCES THAT ENHANCE TARGETED RNA EDITING BY ADAR PROTEINS
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2023
US
WO
2 件公开
CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS FOR RNA EDITING
申请人: AIRNA CORP
优先权: 2024
US
WO
2 件公开
一种18F标记的化合物及豆荚蛋白酶靶向的PET显像探针
申请人: 江苏省原子医学研究所
优先权: 2019
CN
Preparation method of di-((3-chlorobenzothiophene-2-ester) hexafluorophenoxy) axially substituted silicon phthalocyanine
申请人: UNIV FUJIAN
优先权: 2020
CN
CHEMICAL AND SEQUENCE OPTIMISATION OF ANTISENSE OLIGONUCLEOTIDES FOR ADAR-MEDIATED RNA EDITING
申请人: UNIV EBERHARD KARLS TUEBINGEN
优先权: 2023
WO
Cascade targeting PET molecular probe and preparation method and application thereof
申请人: FIRST AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIV
优先权: 2025
CN
药物
反馈